logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

VIVA BIOTECH (01873) spent 404,500 Hong Kong dollars to repurchase 450,000 shares on November 15th.

date
19:15 15/11/2024
avatar
GMT Eight
Viva Biotech (01873) announced that the company spent 404,500 Hong Kong dollars on November 15, 2024...
VIVA BIOTECH (01873) announces that the company has repurchased 450,000 shares on November 15, 2024, at a total cost of 404,500 Hong Kong dollars, with a repurchase price per share ranging from 0.89 to 0.9 Hong Kong dollars.
Related Articles
US Stock Market Move | Storage concept stocks collectively strengthened, Seagate Technology Holdings PLC (STX.US) surged more than 8.6%.
US Stock
Neurocrine (NBIX.US) invests $2.9 billion to acquire Soleno (SLNO.US) to enter the field of metabolic diseases.
China Stock
CMSC: By the middle to late April, the market focus will shift to industries with high growth in first quarter performance.
US Stock Market Move | Storage concept stocks collectively strengthened, Seagate Technology Holdings PLC (STX.US) surged more than 8.6%.
Neurocrine (NBIX.US) invests $2.9 billion to acquire Soleno (SLNO.US) to enter the field of metabolic diseases.
US Stock
CMSC: By the middle to late April, the market focus will shift to industries with high growth in first quarter performance.
China Stock
RECOMMEND
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
icon
02/04/2026
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
icon
02/04/2026
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
icon
02/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.